Advanced search
Publication Cover
Current Medical Research and Opinion Volume 25, 2009 - Issue 3
Submit an article Journal homepage
385
Views
44
CrossRef citations to date
0
Altmetric
Original Article

Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*

Stephen Jones The Academic Centre, James Cook University Hospital, Middlesbrough, UKCorrespondence[email protected]
,
Marian Benroubi Department of Diabetes, Polyclinic General Hospital, Athens, Greece
,
Conxa Castell Department de Salut, Generalitat de Catalunya, Barcelona, Spain
,
Albert Goday Servicio de Endocrinología, Hospital del Mar, Barcelona, Spain
,
Andreas Liebl Center for Diabetes and Metabolism, Fachklinik Bad Heilbrunn, Bad Heilbrunn, Germany
,
Louise Timlin Lilly Research Centre, Windlesham, Surrey, UK
,
Claudia Nicolay Eli Lilly, European Medical, Bad Homburg, Germany
,
Alexander Simpson Lilly Research Centre, Windlesham, Surrey, UK
&
Aodan Tynan Lilly Research Centre, Windlesham, Surrey, UK
 show all
Pages 691-700 | Accepted 09 Jan 2009, Published online: 29 Jan 2009

References

  • Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12
  • Roper NA, Bilous RW, Kelly WF, et al. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ 2001;322:1389-93
  • Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:2568-9
  • Wagner EH, Sandhu N, Newton KM, et al. Effect of improved glycemic control on health care costs and utilization. JAMA 2001;285:181-9
  • Ettaro L, Songer TJ, Zhang P, et al. Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics 2004;22:149-64
  • Leahy JL. Impaired beta-cell function with chronic hyperglycemic; ‘overworked beta-cell’ hypothesis. Diabetes Rev 1996;4:298-319
  • The UK Prospective Diabetes Study Group. UK prospective diabetes study 16: overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 1995;44:1249-58
  • The UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53
  • European Diabetes Policy Group. A desktop guide to Type 2 diabetes mellitus. Diabet Med 1999;16:716-30
  • American Diabetes Association. Standards of medical care in diabetes – 2006. Diabetes Care 2006;29 (Suppl. 1):S4-42
  • Wright A, Burden ACF, Paisey RB, et al. Sulfonylurea inadequacy. Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK. Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002;25:330-6
  • Liebl A, Breitscheidel L, Nicolay C, et al. Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study. Curr Med Res Opin 2008;24:2349-58
  • The International Diabetes Federation (IDF). The IDF Worldwide Definition of the Metabolic Syndrome 2006. Available at: www.idf.org/home/index.cfm?node=1429 [Last accessed 16 July 2007]
  • Resnick HE, Foster GL, Bardsley J, et al. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999–2002: the National Health and Nutrition Examination Survey. Diabetes Care 2006;29:531-7
  • Rubino A, McQuay LJ, Gough SC, et al. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK. Diabet Med 2007;24:1412-18
  • Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: An update. Hypertension 1995;26:869-79
  • Weir MR. Diabetes and hypertension: blood pressure control and consequences. Am J Hypertens 1999;12:170S-8S
  • The UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998;317:703-13
  • Hillier TA, Fosse S, Balkau B, et al. Weight, the metabolic syndrome, and coronary heart disease in Type 2 diabetes: associations among a national French sample of adults with diabetes – The ENTRED Study. Cardiometab Syndr 2006;1:318-25
  • Pischon T, Hu FB, Rexrode KM, et al. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis 2008;197:392-9
  • Hunt KJ, Williams K, Hazuda HP, et al. The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study. Ann Epidemiol 2007;17:870-7
  • Nakar S, Yitzhaki G, Rosenberg R, et al. Transition to insulin in Type 2 diabetes: family physicians’ misconception of patients’ fears contributes to existing barriers. J Diabetes Complications 2007;21:220-6
  • The International Diabetes Federation, European Region (2006). Choosing to take control in type 2 diabetes. Available at: www.diabetes.org.uk/Documents/Reports/Choose_Control_report.pdf [Last accessed 16 July 2007]
  • Choe C, Edelman S. New therapeutic options for treating type-2 diabetes: a review of insulin analogs and premixed insulin analogs. J Natl Med Assoc 2007;99:357-60
  • Cohen A, Horton ES. Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve glycemic control. Curr Med Res Opin 2007;23:905-17
  • Farag A, Karam J, Nicasio J, et al. Prevention of type 2 diabetes: an update. Curr Diab Rep 2007;7:200-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.